Idorsia will take three to four years to reach profitability, CEO says
Jean-Paul Clozel – Billionaire | Phnom Penh HR
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Profile: Jean-Paul Clozel | Nature Biotechnology
Jean-Paul Clozel | EY - Global
Actelion-Gründer erhalten Preis der Vereinigung Starkes Basel
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Was plant das Ehepaar Clozel? | NZZ
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters
Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
J&J snaps up Idorsia's resistant hypertension candidate, paying $230M | Fierce Biotech
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (C) and Actelion CEO and founder Jean-Paul Clozel (R) attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Idorsia : Transforming the Horizons of Therapeutic Options | Insights Care
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg
Jean-Paul Clozel | Financial Times
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook
Biotech visionary Jean-Paul Clozel: "Previous success can be a big handicap," - YouTube
